Filing Details
- Accession Number:
- 0001225208-14-005407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-20 17:09:42
- Reporting Period:
- 2014-02-18
- Filing Date:
- 2014-02-20
- Accepted Time:
- 2014-02-20 17:09:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200666 | C Marc Breslawsky | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-18 | 1,200 | $57.01 | 14,114 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-18 | 1,200 | $54.97 | 15,314 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-18 | 2,400 | $141.34 | 12,914 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2014-02-18 | 1,200 | $0.00 | 1,200 | $54.97 |
| Common Stock | Option (Right to Buy) | Disposition | 2014-02-18 | 1,200 | $0.00 | 1,200 | $57.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-07-14 | No | 4 | M | Direct | |
| 0 | 2014-09-08 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sales price for price increments ranging from $141.34 to $141.3501. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated (formerly known as the 1988 Directors' Stock Award Plan).
- Options fully vested and are currently exercisable.
Billionaire Hedge Funds
